223 related articles for article (PubMed ID: 2123039)
1. Fluvoxamine in the treatment of tricyclic-resistant depression.
White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
[TBL] [Abstract][Full Text] [Related]
2. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
Nathan RS; Perel JM; Pollock BG; Kupfer DJ
J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
Roth D; Mattes J; Sheehan KH; Sheehan DV
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
de Jonghe F; Swinkels J; Tuynman-Qua H
Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
[TBL] [Abstract][Full Text] [Related]
7. Treatment of major affective disorder with fluvoxamine.
Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
[TBL] [Abstract][Full Text] [Related]
8. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
Aberg A
Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
[TBL] [Abstract][Full Text] [Related]
9. A Belgian multicentre study of fluvoxamine in depressive outpatients.
Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
[TBL] [Abstract][Full Text] [Related]
10. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Emrich HM; Berger M; Riemann D; von Zerssen D
Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
[TBL] [Abstract][Full Text] [Related]
11. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
Hamilton BA; Jones PG; Hoda AN; Keane PM; Majid I; Zaidi SI
Pharmatherapeutica; 1989; 5(5):292-7. PubMed ID: 2501801
[TBL] [Abstract][Full Text] [Related]
12. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
[TBL] [Abstract][Full Text] [Related]
13. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
Kasper S; Voll G; Vieira A; Kick H
Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
[TBL] [Abstract][Full Text] [Related]
14. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
Lydiard RB; Laird LK; Morton WA; Steele TE; Kellner C; Laraia MT; Ballenger JC
Psychopharmacol Bull; 1989; 25(1):68-70. PubMed ID: 2505304
[No Abstract] [Full Text] [Related]
15. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine and desipramine in major depressive disorder.
Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
[TBL] [Abstract][Full Text] [Related]
17. Response to desipramine treatment in adolescent major depression.
Boulos C; Kutcher S; Marton P; Simeon J; Ferguson B; Roberts N
Psychopharmacol Bull; 1991; 27(1):59-65. PubMed ID: 1862207
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
Mullin JM; Pandita-Gunawardena VR; Whitehead AM
Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
[No Abstract] [Full Text] [Related]
19. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
[No Abstract] [Full Text] [Related]
20. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
